Medical oncologist Dr. R. Julie Brahmer discusses biomarker testing and advanced treatment for lung cancer patients.

Add Yahoo as a preferred source to see more of our stories on Google. A total of 10,678 cases have been detected since the programme began in 2019 - Prapass Pulsub/Moment RF More than 10,000 people in ...

A new study suggests that a blood-based protein signature may help identify people at risk of lung cancer more accurately ...

A model based on proteins vs. a questionnaire had higher discrimination in predicting lung cancer risk in individuals with a smoking history, according to data presented at the American Thoracic ...

This Nature Outlook is editorially independent, produced with financial support from Daiichi Sankyo and MSD. About this content. A cancer diagnosis of any kind portends a rough road ahead, but that ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Non-small cell lung cancer is ...

Scientists have identified proteins that could signal increased lung cancer risk, as well as a drug that could reduce the odds of a tumor developing. By Nina Agrawal Scientists have made a discovery ...

Every year, about 85,000 Americans are diagnosed with bladder cancer. While treatment is often successful, bladder cancer has one of the highest rates of recurrence of any cancer: Following treatment, ...

Ivonescimab's landmark overall survival win against PD-1 in their chemotherapy combinations in first-line lung cancer drew both hope and criticism at ASCO 2026. (Angus Liu/Fierce Pharma) It’s the ...

NHS mobile scanning units have now identified lung cancer in more than 10,000 patients across England, marking a significant milestone for the screening initiative. Three-quarters of these diagnoses ...

The test can screen for more than 50 types of cancer using a single blood sample, but doctors say it is important to understand both its benefits and limitations. Cancer remains one of the leading ...